Summary: Lemonade, Inc. (NYSE:LMND) director Maria Angelidis-Smith acquired shares in the company on March 10, 2026, in two separate transactions totaling $485,478, according to a Form 4/A filed with the Securities and Exchange Commission. The purchases were executed at prices between $55.30 and $55.70 per share. The stock has appreciated 87% over the past year and is trading at $61.11 with pronounced volatility, per InvestingPro analysis.
Insider purchase details: The filing shows Angelidis-Smith bought 3,350 shares directly at $55.30 per share. In addition, 5,390 shares were acquired indirectly through the Smith Family Trust, of which Angelidis-Smith serves as a Co-Trustee, at $55.70 per share. After these transactions, her direct ownership stands at 14,896 shares and her indirect holdings through the Smith Family Trust total 38,944 shares.
The aggregate dollar value of the two transactions equals $485,478. The reported price range for the purchases was $55.3 to $55.7. InvestingPro analysis notes that LMND has returned 87% over the previous 12 months and is currently quoted at $61.11, while exhibiting high volatility.
Recent company performance and analyst reactions: Lemonade reported fourth-quarter 2025 results that exceeded analyst expectations on both the bottom line and revenue. The company posted earnings per share of -$0.29, ahead of the -$0.39 consensus, and reported revenue of $228 million versus an expected $216.26 million, representing a 5.43% revenue surprise.
Following the earnings release, Keefe, Bruyette & Woods increased its price target for Lemonade to $44 from $40 but retained an Underperform rating, citing stronger premium growth and lower loss ratios as factors. Separately, Morgan Stanley upgraded Lemonade from Equalweight to Overweight, pointing to the strategic potential of Lemonade's partnership with Tesla in the auto insurance market and describing the arrangement as providing a first-mover advantage in data analysis and operational experience.
Other corporate governance developments: In related reporting, Riskified announced that Dr. Samer Haj-Yehia will join its board of directors effective March 19, following the resignation of Aaron Mankovski. The announcement says Dr. Haj-Yehia brings extensive experience in financial services and fintech to the board.
Access to further analysis: For investors seeking deeper valuation work and a more detailed breakdown of Lemonade's financials and outlook, a Pro Research Report is available on InvestingPro.
What this record shows: The Form 4/A disclosure provides a transparent record of the director's purchase activity and the resulting shareholdings. The company’s recent quarterly results and subsequent analyst responses are included in public filings and market commentary cited above.